Compare Kroger Co (KR) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kroger Co vs Twist Bioscience Corp — how do they compare? Kroger Co trades at $57.74 (market cap $35.75B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Kroger Co is far larger — about 6.6× Twist Bioscience Corp's market cap, and Kroger Co pays a 2.47% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| KR | TWST | |
|---|---|---|
Market Cap | $35.75B | $5.45B |
Sector | Consumer Staples | Health |
52-Week High | $75.60 | $102.88 |
52-Week Low | $55.53 | $24.16 |
Enterprise Value | $55.85B | $5.37B |
Dividend Yield | 2.47% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kroger Co
Kroger is the leading American grocer, with 2,726 supermarkets operating under several banners throughout the country as of the end of fiscal 2021. Around 83% of stores have pharmacies, while nearly 60% also sell fuel. The company also operates roughly 120 fine jewelry stores. Kroger features a leading private-label offering and manufactures around 30% of its own-brand units (and more than 40% of its grocery own-label assortment) itself, in 33 food production plants nationwide. Kroger is a top-two grocer in most of its major markets (as of early 2021, according to company data). Virtually all of Kroger's sales come from the United States.
Read more on KR →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
